Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Uganda Newborn Survival Study: improving newborn health and survival through a community based intervention linked to health facilities
ISRCTN ISRCTN50321130
ClinicalTrials.gov identifier
Public title Uganda Newborn Survival Study: improving newborn health and survival through a community based intervention linked to health facilities
Scientific title Improving newborn health and survival through a community based intervention linked to health facilities: a randomised controlled cluster trial
Acronym UNEST
Serial number at source N/A
Study hypothesis Implementation of an integrated care package of four home visits by a community health worker (CHW) during pregnancy and the neonatal period to deliver one on one health messages and promoting linkage to the health facility improves the following maternal-newborn care practices by at least 20% in two years amongst the target population in rural Uganda.
Lay summary
Ethics approval Uganda National Council of Science and Technology HS626 approved from the 20th August 2009 to 20th August 2010.
Study design Randomised controlled cluster trial
Countries of recruitment Uganda
Disease/condition/study domain Maternal and newborn health
Participants - inclusion criteria 1. Women of childbearing age
2. Pregnant women
3. Newly delivered women
4. Neonates and infants
Participants - exclusion criteria Refusal to consent
Anticipated start date 01/07/2009
Anticipated end date 30/12/2011
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 65 villages, 70000 people
Interventions Through formative research around evidence-based practices, and dialogue with policy and technical advisors, we will construct a home-based neonatal care package implemented by the responsible Village Health Team member, effectively a Community Health Worker. This CHW will be trained to identify pregnant women and make four home visits: two before and two just after birth. Linkages will be made to facility care and targeted messages for home-care and care-seeking delivered. The project will improve care in health units to provide standardised care for the mother and the newborn in both intervention and comparison areas.

The control area is being given the current standard of care provided by the Government. However, health facility quality improvement initiatives are being provided in both control and intervention areas in order to standardise care but also for ethical reasons. This will enable sick newborns in the control area to access care.
Primary outcome measure(s) 1. In ANC:
1.1. % of pregnant women attending ANC two, four or more times
1.2. % of pregnant women who know at least two danger signs of pregnancy
1.3. % of pregnant women who prepare for birth

2. In the intrapartum period:
2.1. % of pregnant women who have a skilled attendant at delivery
2.2. % of women who went to the HC in an emergency

3. In the post-natal period:
3.1. % of babies who are initiated on breastfeeding in the first 6 hours of birth
3.2. % of babies who are exclusively breastfed during the neonatal period
3.3. % of babies whose first bath was delayed for 6 and 24 hours
3.4. % of mothers who put nothing on the cord
3.5. % of mothers who know at least 3 neonatal danger signs
3.6. % women whose children were managed in skin to skin contact after delivery.
3.7. Effectiveness of sepsis management (special studies to determine: maternal and CHW knowledge, compliance and timing of referral, and adequacy of treatment following referral)
Secondary outcome measure(s) 1. Neonatal mortality
2. Perinatal mortality
Sources of funding Save the Children (USA) (ref: UG01_232)
Trial website
Publications 1. 2008 acceptability results: http://www.ncbi.nlm.nih.gov/pubmed/18570672
2. 2009 population study: http://www.ncbi.nlm.nih.gov/pubmed/19710561
Contact name Prof  George  Pariyo
  Address Makerere University
School of Public Health
College of Health Sciences
P.O Box 7072
  City/town Kampala
  Zip/Postcode -
  Country Uganda
  Tel +256 (0)41 453 0291
  Fax +256 (0)41 454 0633
  Email gpariyo@musph.ac.ug
Sponsor Save the Children (USA)
  Address 2000 L Street NW
Suite 500
DC 20036 202.640.6661
  City/town Washington
  Zip/Postcode 2000
  Country United States of America
  Tel +1 203 221 4030
  Fax +1 203 221 4030
  Email twebster@savechildren.org
  Sponsor website: http://www.savechildren.org
Date applied 31/10/2009
Last edited 17/02/2010
Date ISRCTN assigned 17/02/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central